ROBIN HOWARD W
SEC CIK 1206869 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | Pres, CEO, Dir | 54.6K | — | $3.81M | 33 | 2021-08-16 | 2026-08-18 |
Most active insiders at NKTR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBIN HOWARD W | Pres, CEO, Dir | — | $1.42M |
| 2 | Zalevsky Jonathan | Chief R, D Off | — | $974.2K |
| 3 | Wilson Mark Andrew | CLO | — | $34.2K |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 19:03 | 2026-08-18 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $71.98 | -418 | 54.6K | -0.8% | -$30.1K | |
| MT | 2026-06-18 19:08 | 2026-06-16+ | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $60.75 | -20.0K | 55.0K | -27% | -$1.22M |
| 2026-05-21 18:26 | 2026-05-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $65.51 | -444 | 75.0K | -0.6% | -$29.1K | |
| 2026-02-20 | 2026-02-18 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $73.00 | -423 | 75.5K | -0.6% | -$30.9K | |
| D | 2025-12-23 | 2025-12-22 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +21.7K | 75.9K | +40% | $0 |
| D | 2025-11-25 | 2025-11-25 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $54.28 | -2,207 | 54.2K | -4% | -$119.8K |
| D | 2025-11-25 | 2025-11-21 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +7,110 | 56.5K | +14% | $0 |
| MT | 2025-09-11 | 2025-09-09 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $46.69 | -6,666 | 49.3K | -12% | -$311.2K |
| MT | 2025-09-08 | 2025-09-04+ | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $36.42 | -11.8K | 56.0K | -17% | -$431.0K |
| T | 2025-09-04 | 2025-09-02 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $30.16 | -1,500 | 67.8K | -2% | -$45.2K |
| D | 2025-08-21 | 2025-08-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $26.59 | -1,573 | 69.3K | -2% | -$41.8K |
| 2025-05-21 | 2025-05-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.67 | -23.2K | 1.06M | -2% | -$15.5K | |
| 2025-02-21 | 2025-02-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $1.01 | -23.8K | 1.09M | -2% | -$24.0K | |
| M | 2024-12-19 | 2024-12-17+ | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.9971 | -132.0K | 1.11M | -11% | -$131.6K |
| D | 2024-12-17 | 2024-12-13 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +410.6K | 1.24M | +49% | $0 |
| 2024-11-20 | 2024-11-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $1.01 | -16.3K | 832.1K | -2% | -$16.4K | |
| 2024-08-20 | 2024-08-19 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $1.28 | -14.9K | 848.4K | -2% | -$19.0K | |
| 2024-05-20 | 2024-05-17 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $1.75 | -16.6K | 863.2K | -2% | -$29.1K | |
| 2024-02-22 | 2024-02-20 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.68 | -20.0K | 879.9K | -2% | -$13.6K | |
| 2023-11-20 | 2023-11-17 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.49 | -19.9K | 899.9K | -2% | -$9,740 | |
| 2023-08-17 | 2023-08-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.78 | -20.0K | 919.8K | -2% | -$15.6K | |
| 2023-05-17 | 2023-05-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $0.72 | -20.4K | 939.8K | -2% | -$14.7K | |
| 2023-02-17 | 2023-02-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $3.00 | -19.6K | 960.2K | -2% | -$58.9K | |
| 2022-11-18 | 2022-11-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $3.57 | -38.0K | 979.8K | -4% | -$135.7K | |
| D | 2022-08-17 | 2022-08-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $4.76 | -13.8K | 1.02M | -1% | -$65.5K |
| D | 2022-08-17 | 2022-08-15 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +410.6K | 1.03M | +66% | $0 |
| 2022-05-17 | 2022-05-15 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +68.5K | 657.5K | +12% | $0 | |
| 2022-05-17 | 2022-05-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $3.95 | -36.5K | 620.9K | -6% | -$144.3K | |
| 2022-02-18 | 2022-02-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $10.95 | -12.5K | 589.0K | -2% | -$136.7K | |
| D | 2021-12-20 | 2021-12-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +126.0K | 601.5K | +27% | $0 |
| 2021-11-17 | 2021-11-15 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +94.1K | 518.2K | +22% | $0 | |
| 2021-11-17 | 2021-11-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $13.16 | -42.8K | 475.4K | -8% | -$562.9K | |
| 2021-08-18 | 2021-08-16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Pres, CEO, Dir | S - Sale | $13.83 | -11.5K | 424.1K | -3% | -$159.3K |
Purchase Sale Sale after option exercise All abbreviations